Physician profile
Noemi Maydew
NPI 1407820756
$3,550.11
in general payments reported to CMS, 2019-2025
35 companies · $484 in 2025
The $484 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $273 · 2021: $645 · 2022: $517 · 2023: $777 · 2024: $243 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $677.61 | 2019-2025 | |
| Abbvie INC. | $405.64 | 2019-2025 | |
| Hologic Sales and Service, LLC | $261.22 | 2022-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $216.56 | 2023-2025 | Veozah |
| Myriad Women'S Health, INC. | $213.97 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $198.86 | 2019-2025 | |
| Pfizer INC. | $186.43 | 2019-2025 | |
| Therapeuticsmd, INC. | $169.55 | 2019-2022 | |
| Boston Scientific Corporation | $130.98 | 2023 | |
| Exeltis, USA INC. | $120.85 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $110.73 | 2019-2025 | Endosee |
| Myovant Sciences INC. | $94.46 | 2021-2022 | |
| Evofem Biosciences, INC. | $92.91 | 2021-2025 | Solosec, Phexx, Phexxi |
| Avion Pharmaceuticals | $81.18 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $73.22 | 2025 | Myfembree |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $72.16 | 2022-2024 | |
| Daiichi Sankyo INC. | $53.30 | 2020-2021 | |
| Duchesnay USA Incorporated | $52.96 | 2019 | |
| Aspira Women'S Health INC | $43.49 | 2022 | |
| Davol INC. | $37.46 | 2021 | |
| Ethicon US, LLC | $30.70 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.60 | 2019 | |
| Sanofi Pasteur INC. | $23.70 | 2025 | |
| Abbott Laboratories | $22.35 | 2021 | |
| Agile Therapeutics, INC. | $20.72 | 2023 | Twirla |
| Medicem INC. | $18.04 | 2020 | |
| Meditrina | $15.82 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $15.42 | 2024 | |
| Millicent US INC | $15.04 | 2025 | Femlyv |
| Terumo Medical Corporation | $14.90 | 2020 | |
| Merck Sharp & Dohme LLC | $14.48 | 2023 | Gardasil 9 |
| Roche Diagnostics Corporation | $14.25 | 2019 | |
| Allergan, INC. | $13.67 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noemi Maydew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.